Get started
Author

Xinqun Yang

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
2014 · A. Keith Stewart, S. Vincent Rajkumar, et al. · New England Journal of Medicine · 1,334
PDF
Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer
2010 · Jean-Charles Soria, Egbert Smit, et al. · Journal of Clinical Oncology · 231
Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A
2021 · K John Pasi, Michael Laffan, et al. · Haemophilia · 96
PDF
Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma
2016 · A. Keith Stewart, Meletios A. Dimopoulos, et al. · Journal of Clinical Oncology · 79
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma
2010 · Patrick Schöffski, Jorge A. Garcia, et al. · British Journal of Urology · 71
An Open-Label Clinical Trial Evaluating Safety and Pharmacokinetics of Two Dosing Schedules of Panitumumab in Patients with Solid Tumors
2009 · Joe J. Stephenson, Charles Gregory, et al. · Clinical Colorectal Cancer · 43
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
2024 · Johannes Oldenburg, Herve Chambost, et al. · Advances in Therapy · 5
PDF
Phase Ib study of AMG 386 in combination with paclitaxel (P) and carboplatin (C) in high-risk stage I and stages II-IV epithelial ovarian, primary peritoneal, or fallopian tube cancers.
2012 · Antonio Casado, Ana Oaknin, et al. · Journal of Clinical Oncology · 2
Works count: 8
Citation count: 1,861
H-index: 6
I10-index: 6
Year
Topic
Type